Work

Phase I/II study of docetaxel and 153Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.5057

Authors: M. J. Morris, N. Pandit-Taskar, R. D. Stephenson, C. Hong, S. F. Slovin, D. Rathkopf, D. Solit, J. Carrasquillo, S. Larson, H. I. Scher

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2243448288

Cites:

Cited by: 8

Related to: 10